2. Academic Validation
  3. TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis

TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis

  • Curr Med Sci. 2022 Oct 17. doi: 10.1007/s11596-022-2655-8.
Qian-Zhi Chen # 1,  Yan Chen # 2,  Xia Li 3,  Hao Liu 4,  Xu-Ling Sun 5
Affiliations

Affiliations

  • 1 Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • 2 Department of Hematology, Wuhan No. 1 Hospital, Wuhan, 430022, China.
  • 3 Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, 832000, China.
  • 4 Department of Gastroenterology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, 832000, China. [email protected].
  • 5 Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, 832000, China. [email protected].
  • # Contributed equally.
PMID: 36245025 DOI: 10.1007/s11596-022-2655-8
Abstract

Objective: Vascular endothelial growth factor A (VEGFA) is a key regulator of angiogenesis, which is a hallmark of Cancer that promotes Cancer growth and metastasis. It is of great significance to find new intervention targets and related regulatory mechanisms of VEGFA related angiogenesis for the treatment of tumors. This study focuses on the role of tribbles pseudokinase 3 (TRIB3)/signal transducer and activator of transcription 3 (STAT3)/VEGFA signaling axis in colon Cancer angiogenesis.

Methods: This study investigated the expression level of TRIB3 in colon Cancer through database analysis and tissue microarray analysis. The effect of TRIB3 on proliferation, migration and tube formation ability of human umbilical vein endothelial cells (HUVECs) was further confirmed by CCK8 assay, scratch-wound assay/migration assay and tube formation assay respectively. The regulatory relationship of TRIB3/VEGFA signaling axis was identified by qPCR and Western blotting, which was further confirmed through animal experiments, and the specific regulatory mechanism was explored by immunoprecipitation (IP) and chromatin immunoprecipitation (ChIP) with colon Cancer cell lines.

Results: TRIB3 was increased in colon Cancer tissues compared to normal tissues, and elevated TRIB3 expression indicated a poor prognosis in colon Cancer patients. Moreover, it was found that silencing TRIB3 could inhibit Cancer angiogenesis, whereas overexpressing TRIB3 promoted Cancer angiogenesis in vitro and in vivo. Mechanistically, TRIB3 physically interacted with STAT3 and enhanced STAT3-mediated transcriptional activity. Furthermore, the function of TRIB3 in Cancer angiogenesis was through cooperating with STAT3 to increase the VEGFA expression.

Conclusion: Our study provides insights into Cancer angiogenesis and offers a potential therapeutic strategy for TRIB3-overexpressed Cancer.

Keywords

angiogenesis; cancer; signal transducer and activator of transcription 3; tribbles pseudo-kinase 3; vascular endothelial growth factor.

Figures
Products